Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing.

AGORANOV

Worldwide Innovation Challenge

European Commission

CARB-X

EASME - EU Executive Agency for SMEs

Seventure Partners

Khosla Ventures

Bpifrance

Sanofi Ventures

Eligo Bioscience

Exciting times at Eligo! Following our Series B announcement, we're gearing up to take the first-ever topical CRISPR therapy to the clinic. 
If you're eager to have a meaningful impact on the lives of millions of patients, we would love to hear from you. 
We are indeed on the lookout for passionate and driven individuals to join our Development, Finance, Synthetic Biology & Bioinformatics teams.

https://eligo.bio/careers/

🎉 News alert: We are thrilled to announce that we have just closed a $30 million financing round led by Sanofi Ventures, with the participation of Bpifrance (Innobio2), and our existing investors Khosla Ventures and Seventure Partners.

 🧬 This funding will enable us to advance and test in the clinic our CRISPR-based medicine for the 90M+ patients suffering from moderate-to-severe acne vulgaris. It will also help us to further develop our proprietary platform to address other immuno-inflammatory diseases, cancers, and infectious diseases.

 🚀 This is a defining moment for Eligo as this funding places us in a strong position to make a significant leap in treating diseases by editing the genetic makeup of the human microbiome.

#CRISPR #SyntheticBiology #GeneEditing #Microbiome #Acnetreatment 

https://lnkd.in/ejTC-DXS

Locus Biosciences operates as a precision medicine company focused on the development of CRISPR-engineered precision antimicrobials for the treatment of bacterial infections.

Locus Biosciences

Proteon Pharmaceuticals

Synlogic focuses on the development of synthetic biotic medicines for the treatment of metabolic and inflammatory diseases.

Synlogic

eGenesis is a biotechnology company engaged in the development of xenotransplantation therapies for patients with end-stage organ failure.

eGenesis

Scribe Therapeutics is a biotechnology company focused on the development of CRISPR-based genetic medicines for the treatment of genetic diseases.

Scribe Therapeutics

Tessera Therapeutics is a biotechnology company specializing in gene writing, a new biotechnology that enables the programming and reprogramming of the human genome.

Tessera Therapeutics

Korro Bio

Evofem is a biopharmaceutical company focused on the development and commercialization of innovative products to address unmet needs in women's sexual and reproductive health.

Evofem

Synthego is a biotechnology company that provides genome engineering solutions using CRISPR technology.

Synthego

Ginkgo Bioworks is a biotechnology company that designs custom microbes for customers across multiple markets, including food, agriculture, and pharmaceuticals.

Ginkgo Bioworks

Eligo Bioscience is a biotechnology company focused on the development of innovative microbiome therapies. The company leverages cutting-edge technology to engineer beneficial microbes that can specifically target and eliminate harmful bacteria, aiming to treat a range of diseases linked to the human microbiome.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	May 12, 2024 6:36 PM	eb128e38
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 12, 2024 11:24 PM	b426c609
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 12, 2024 6:36 PM	5fd17faa
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 12, 2024 6:36 PM	cbb9a204
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

BIO:ELIGO

Eligo Bioscience